Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Gilead Sciences Inc (GILD)  
$65.20 0.74 (1.12%) as of 4:30 Tue 4/30


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 1,250,000,000
Market Cap: 81.50(B)
Last Volume: 7,436,599 Avg Vol: 8,754,576
52 Week Range: $65.27 - $87.29
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     NASDAQ-100
    S&P 500     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  259
Guru Rank Value     : 4.6
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include viral diseases, inflammatory diseases and oncology. Co.'s products include: Biktarvy® for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), for the treatment of Coronavirus Disease 2019 requiring hospitalization; Epclusa® for the treatment of chronic hepatitis C virus infection; Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; Yescarta® (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 12,230 25,472 38,458 80,792
Total Sell Value $890,904 $2,022,270 $3,052,046 $6,445,296
Total People Sold 1 3 3 4
Total Sell Transactions 3 5 9 14
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 2493
  Page 6 of 100  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mercier Johanna Chief Commercial Officer   •       •      –    2022-12-10 4 D $87.97 $40,730 D/D (463) 40,430     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2022-12-10 4 OE $0.00 $0 D/D 990 40,893     -
   Parsey Merdad Chief Medical Officer   •       •      –    2022-11-10 4 D $82.60 $187,337 D/D (2,268) 45,556     -
   Parsey Merdad Chief Medical Officer   •       •      –    2022-11-10 4 OE $0.00 $0 D/D 5,099 47,824     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2022-11-10 4 D $82.60 $70,293 D/D (851) 68,668     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2022-11-10 4 OE $0.00 $0 D/D 1,912 69,519     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2022-11-09 4 S $83.50 $535,736 D/D (6,416) 28,333 4%     
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2022-11-09 4 OE $63.91 $410,047 D/D 6,416 34,749     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2022-11-01 4 S $79.25 $1,288,209 D/D (16,255) 28,333 -0%     
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2022-11-01 4 OE $72.70 $1,181,739 D/D 16,255 44,588     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2022-09-10 4 D $65.28 $99,748 D/D (1,528) 252,878     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2022-09-10 4 OE $0.00 $0 D/D 3,301 254,406     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2022-09-10 4 D $65.28 $29,898 D/D (458) 39,903     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2022-09-10 4 OE $0.00 $0 D/D 990 40,361     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2022-09-10 4 D $65.28 $9,661 D/D (148) 28,333     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2022-09-10 4 OE $0.00 $0 D/D 318 28,481     -
   Parsey Merdad Chief Medical Officer   •       •      –    2022-09-10 4 D $65.28 $31,400 D/D (481) 42,725     -
   Parsey Merdad Chief Medical Officer   •       •      –    2022-09-10 4 OE $0.00 $0 D/D 1,039 43,206     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2022-09-10 4 D $65.28 $31,073 D/D (476) 67,607     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2022-09-10 4 OE $0.00 $0 D/D 1,027 68,083     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2022-08-10 4 D $63.14 $67,307 D/D (1,066) 28,163     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2022-08-10 4 OE $0.00 $0 D/D 2,479 29,229     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2022-07-24 4 D $60.80 $194,925 D/D (3,206) 39,371     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2022-07-24 4 OE $0.00 $0 D/D 7,505 42,577     -
   Parsey Merdad Chief Medical Officer   •       •      –    2022-06-10 4 D $60.74 $29,459 D/D (485) 42,167     -
  2493 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 100
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us